Valuation: AbbVie Inc.

Market Cap 442B 14,646B 382B 359B 327B 615B 42,384B 624B 4,217B 1,653B 21,198B 1,661B 1,625B 70,609B P/E 2026 *
32x
P/E 2027 * 23.6x
Enterprise Value 503B 16,648B 434B 409B 371B 699B 48,180B 709B 4,793B 1,879B 24,097B 1,888B 1,847B 80,264B EV / Sales 2026 *
7.44x
EV / Sales 2027 * 6.72x
Free-Float
95.71%
Yield 2026 *
2.74%
Yield 2027 * 2.88%
1 day+0.61%
1 week+1.23%
Current month-4.07%
1 month-4.07%
3 months+20.44%
6 months+14.58%
Current year+13.01%
1 week 8.2
Extreme 8.2
8.45
1 month 8
Extreme 8
8.85
Current year 6.25
Extreme 6.25
8.85
1 year 6.25
Extreme 6.25
8.85
3 years 6.25
Extreme 6.25
8.85
5 years 6.25
Extreme 6.25
8.85
10 years 6.25
Extreme 6.25
8.85
Manager TitleAgeSince
Chief Executive Officer 55 01/07/2024
Director of Finance/CFO 59 23/06/2022
Chief Tech/Sci/R&D Officer - 01/03/2024
Director TitleAgeSince
Director/Board Member 65 01/01/2013
Director/Board Member 74 01/01/2013
Director/Board Member 69 01/01/2013
Change 5-day change 1-year change 3-year change Capi.($)
+0.61%+1.23% - - 442B
+2.53%+0.21%+74.43%+122.83% 1,055B
+2.99%+4.22%+53.63%+56.97% 632B
+2.89%+3.04%+24.74%+71.63% 442B
+1.35%-2.17%+40.98%+41.50% 351B
+1.75%-0.24%+25.28%+40.46% 290B
+2.13%-0.32%+0.58%+10.77% 243B
+1.45%+2.62%+45.29%+62.39% 227B
+1.35%-3.53%-14.72%-52.63% 200B
+3.12%+5.35%+21.22%+88.49% 172B
Average +2.07%-1.44%+30.16%+49.16% 401.39B
Weighted average by Cap. +2.20%-1.87%+43.23%+67.82%

Financials

2026 *2027 *
Net sales 67.58B 2,238B 58.37B 54.92B 49.92B 93.88B 6,476B 95.26B 644B 252B 3,239B 254B 248B 10,788B 73.52B 2,434B 63.5B 59.74B 54.3B 102B 7,044B 104B 701B 275B 3,523B 276B 270B 11,735B
Net income 13.86B 459B 11.97B 11.26B 10.24B 19.26B 1,328B 19.54B 132B 51.78B 664B 52.04B 50.91B 2,213B 18.91B 626B 16.34B 15.37B 13.97B 26.27B 1,812B 26.66B 180B 70.66B 906B 71.01B 69.47B 3,019B
Net Debt 60.49B 2,003B 52.25B 49.16B 44.68B 84.03B 5,796B 85.26B 577B 226B 2,899B 227B 222B 9,655B 51.66B 1,710B 44.62B 41.98B 38.16B 71.76B 4,950B 72.82B 492B 193B 2,476B 194B 190B 8,246B
Logo AbbVie Inc.
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (76.2%), Germany (2.8%), Japan (2.1%), Canada (2%), China (1.6%), France (1.3%), the United Kingdom (1%), Spain (1%), Italy (0.9%), Brazil (0.8%), Australia (0.8%), and Other (9.5%).
Employees
57,000
Date Price Change Volume
18/08/26 THB 8.250 +0.61% 25,004
17/08/26 THB 8.200 -1.80% 9,495
14/08/26 THB 8.350 +1.21% 220,433
13/08/26 THB 8.250 +0.61% 211,605
11/08/26 THB 8.200 +0.61% 32,594
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
250.33USD
Average target price
276.41USD
Spread / Average Target
+10.42%

Quarterly revenue - Rate of surprise